Taro Pharmaceutical Industries Ltd (NYSE:TARO)

87.27
Delayed Data
As of Nov 15
 +11.05 / +14.50%
Today’s Change
72.97
Today|||52-Week Range
109.42
+3.11%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 110.00, with a high estimate of 110.00 and a low estimate of 110.00. The median estimate represents a +26.05% increase from the last price of 87.27.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.54
Sales
$172.0M
Reporting Date
Feb 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.48%
 
 
 
 
 
 
Growthannually -10.79%
 
 
 
 
 
 

Sales

Growthquarterly 6.94%
 
 
 
 
 
 
Growthannually 1.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.